building rental and expenses, and reversal of loss on impairment of investment properties in Baht 25.6 million and reversal of loss on impairment of assets in Baht 7.0 million. Financial Cost Financial cost
million baht from 268.6 million baht in the year ended 31 December 2016 due to the cost control policy of the Company. Consolidated allowance for impairment of goodwill for the year ended 31 December 2017
stock a subsidiary and reverse allowance for doubtful accounts Page 2 of 3 investment in associated companies and reversal of impairment assets THB 15.57 million. 2. The cost of goods sold and services of
398.21 314.81 Administrative expenses 460.64 414.05 Loss from Impairment of Investment 56.89 - Finance costs 61.87 92.81 Finance costs (net) 46.22 83.33 Proportion of cost of medical treatment / revenue of
Administrative expenses 75.07 89.35 -15.98 65.82 84.57 -22.17 Loss on allowance for doubtful accounts of loans to subsidiary - - - - Loss on impairment of investment in subsidiary 0.00 Loss on impairment of
written-off the licences for publication from their restructuring of Baht 204.45 million. The subsidiary and indirect subsidiary recognised impairment loss of digital terrestrial television licenses and
Cost of services 13.43 3.99 9.44 236.59 Cost of impairment 101.63 108.78 -7.15 -6.57 Loss in sale of subsidairy company 3.09 0.00 3.09 Administrative expenses 133.99 141.00 -7.01 -4.97 Finance cost 25.18
equipment 614.09 407.46 Administrative expenses 516.93 486.11 Loss from Impairment of Investment 248.04 56.89 Finance costs 46.17 61.87 Finance costs (net) 32.25 46.22 Proportion of cost of medical treatment
% Profit (Loss) before the effects of foreign exchange, deferred income tax, impairment and lease income 23,126 9,054 246 214 23,372 9,268 14,104 100% Loss from impairment (2,619) (352) - - (2,619) (352
increase losses 18.70% because the company set aside allowance for impairment of loan receivables from purchase of non-performing debts decreased from the previous year is significant. Please be informed